9 results
Synthroid color-coded tablets and initial dosing

#pharmacology #dosing #medications #drugs #overview
tablets and initial dosing ... #pharmacology ... #dosing #medications ... #drugs #overview
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
Statins intensity, drug ... An overview of high ... #pharmacology #overview ... #medications #comparison ... #drugs #table
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
tablets, initial dosing ... INR targets #pharmacology ... #overview #review ... #medications #drugs
Long-acting injectable antipsychotics

Follow www.instagram.com/rxnotes for more!
#pharmacology #overview #comparison #dosing #psychiatry #medications #review #drugs #antipsychotics
#pharmacology #overview ... #comparison #dosing ... #psychiatry #medications ... #review #drugs
Bisphosphonates for Osteoporosis Treatment or Prevention 

Bisphosphonates are common medications used in the treatment and prevention
Bisphosphonates are common medications ... There are 4 drugs ... are a variety of dosing ... Schedule #Frequency #Pharmacology ... #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... thing about this drug ... This drug class ... #Pharmacology # ... Diabetes #DM2 #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... take any other medications ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Syndrome (PRES) Overview ... Neurological symptoms ... Electrolyte abnormality, Medication ... /Drug toxicity, ... diagnosis #management #neurology
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Receptor Antagonist Indication ... of Migraines: Dosing ... reported this drug ... #Pharmacology # ... Dosing